Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” (Bioorganic & Medicinal Chemistry Letters (2019) 29(8) (995–1000), (S0960894X19300873), (10.1016/j.bmcl.2019.02.011))

Maria B. Goncalves; Earl Clarke; Christopher I. Jarvis; S. Barret Kalindjian; Thomas Pitcher; John Grist; Carl Hobbs; Thomas Carlstedt; Julian Jack; Jane T. Brown; Mark Mills; Peter Mumford; Alan D. Borthwick; Jonathan P.T. Corcoran

doi:10.1016/j.bmcl.2019.05.058

Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” (Bioorganic & Medicinal Chemistry Letters (2019) 29(8) (995–1000), (S0960894X19300873), (10.1016/j.bmcl.2019.02.011))

Maria B. Goncalves, Earl Clarke, Christopher I. Jarvis, S. Barret Kalindjian, Thomas Pitcher, John Grist, Carl Hobbs, Thomas Carlstedt, Julian Jack, Jane T. Brown, Mark Mills, Peter Mumford, Alan D. Borthwick^*, Jonathan P.T. Corcoran

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors regret that a mistake was made in the headings of Tables 2 and 3. The correct Tables 2 and 3 appear below. The authors would like to apologise for any inconvenience caused.

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS
DOIs	https://doi.org/10.1016/j.bmcl.2019.05.058
Publication status	Published - 14 Jun 2019

Access to Document

10.1016/j.bmcl.2019.05.058

Fingerprint

Dive into the research topics of 'Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” (Bioorganic & Medicinal Chemistry Letters (2019) 29(8) (995–1000), (S0960894X19300873), (10.1016/j.bmcl.2019.02.011))'. Together they form a unique fingerprint.

Cite this

Goncalves, M. B., Clarke, E., Jarvis, C. I., Kalindjian, S. B., Pitcher, T., Grist, J., Hobbs, C., Carlstedt, T., Jack, J., Brown, J. T., Mills, M., Mumford, P., Borthwick, A. D., & Corcoran, J. P. T. (2019). Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” (Bioorganic & Medicinal Chemistry Letters (2019) 29(8) (995–1000), (S0960894X19300873), (10.1016/j.bmcl.2019.02.011)). BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, 1-2. https://doi.org/10.1016/j.bmcl.2019.05.058

Goncalves, Maria B. ; Clarke, Earl ; Jarvis, Christopher I. et al. / Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” (Bioorganic & Medicinal Chemistry Letters (2019) 29(8) (995–1000), (S0960894X19300873), (10.1016/j.bmcl.2019.02.011)). In: BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS. 2019 ; pp. 1-2.

@article{f3b9d0d99b6744c09bd0cd2e37058d75,

title = "Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” (Bioorganic & Medicinal Chemistry Letters (2019) 29(8) (995–1000), (S0960894X19300873), (10.1016/j.bmcl.2019.02.011))",

abstract = "The authors regret that a mistake was made in the headings of Tables 2 and 3. The correct Tables 2 and 3 appear below. The authors would like to apologise for any inconvenience caused.",

author = "Goncalves, {Maria B.} and Earl Clarke and Jarvis, {Christopher I.} and Kalindjian, {S. Barret} and Thomas Pitcher and John Grist and Carl Hobbs and Thomas Carlstedt and Julian Jack and Brown, {Jane T.} and Mark Mills and Peter Mumford and Borthwick, {Alan D.} and Corcoran, {Jonathan P.T.}",

year = "2019",

month = jun,

day = "14",

doi = "10.1016/j.bmcl.2019.05.058",

language = "English",

pages = "1--2",

journal = "BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS",

issn = "0960-894X",

publisher = "Elsevier Limited",

}

Goncalves, MB , Clarke, E , Jarvis, CI , Kalindjian, SB , Pitcher, T, Grist, J, Hobbs, C, Carlstedt, T, Jack, J, Brown, JT, Mills, M, Mumford, P, Borthwick, AD & Corcoran, JPT 2019, 'Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” (Bioorganic & Medicinal Chemistry Letters (2019) 29(8) (995–1000), (S0960894X19300873), (10.1016/j.bmcl.2019.02.011))', BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, pp. 1-2. https://doi.org/10.1016/j.bmcl.2019.05.058

Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” (Bioorganic & Medicinal Chemistry Letters (2019) 29(8) (995–1000), (S0960894X19300873), (10.1016/j.bmcl.2019.02.011)). / Goncalves, Maria B.; Clarke, Earl ; Jarvis, Christopher I. et al.
In: BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, 14.06.2019, p. 1-2.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” (Bioorganic & Medicinal Chemistry Letters (2019) 29(8) (995–1000), (S0960894X19300873), (10.1016/j.bmcl.2019.02.011))

AU - Goncalves, Maria B.

AU - Clarke, Earl

AU - Jarvis, Christopher I.

AU - Kalindjian, S. Barret

AU - Pitcher, Thomas

AU - Grist, John

AU - Hobbs, Carl

AU - Carlstedt, Thomas

AU - Jack, Julian

AU - Brown, Jane T.

AU - Mills, Mark

AU - Mumford, Peter

AU - Borthwick, Alan D.

AU - Corcoran, Jonathan P.T.

PY - 2019/6/14

Y1 - 2019/6/14

N2 - The authors regret that a mistake was made in the headings of Tables 2 and 3. The correct Tables 2 and 3 appear below. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that a mistake was made in the headings of Tables 2 and 3. The correct Tables 2 and 3 appear below. The authors would like to apologise for any inconvenience caused.

U2 - 10.1016/j.bmcl.2019.05.058

DO - 10.1016/j.bmcl.2019.05.058

M3 - Comment/debate

AN - SCOPUS:85067210637

SN - 0960-894X

SP - 1

EP - 2

JO - BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS

JF - BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS

ER -

Goncalves MB , Clarke E , Jarvis CI , Kalindjian SB , Pitcher T, Grist J et al. Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” (Bioorganic & Medicinal Chemistry Letters (2019) 29(8) (995–1000), (S0960894X19300873), (10.1016/j.bmcl.2019.02.011)). BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS. 2019 Jun 14;1-2. doi: 10.1016/j.bmcl.2019.05.058